Breakdown | Dec 2023 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 10.03M | 99.47K | 248.47K | 369.64K | 708.43K |
Gross Profit | ― | 98.53K | 247.22K | 368.58K | 706.75K |
EBITDA | ― | -631.08K | -495.71K | -1.24M | 506.99K |
Net Income | ― | -826.96K | -794.51K | -1.46M | 2.16M |
Balance Sheet | |||||
Total Assets | 11.56M | 9.27M | 9.75M | 10.01M | 9.29M |
Cash, Cash Equivalents and Short-Term Investments | 2.55M | 5.18M | 6.64M | 723.94K | 3.75M |
Total Debt | 2.71M | 2.28M | 138.15K | 1.58M | 0.00 |
Total Liabilities | 5.07M | 2.81M | 2.47M | 2.09M | 76.13K |
Stockholders Equity | 7.49M | 6.45M | 7.28M | 7.92M | 9.22M |
Cash Flow | |||||
Free Cash Flow | -938.34K | ― | 5.92M | -3.05M | -1.04M |
Operating Cash Flow | -765.73K | -1.56M | 5.92M | -3.05M | -1.04M |
Investing Cash Flow | -383.10K | ― | ― | 0.00 | 0.00 |
Financing Cash Flow | -126.26K | ― | -4.18K | 26.92K | -68.78K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
56 Neutral | $1.89B | ― | -12.60% | ― | 4.92% | -64.84% | |
52 Neutral | C$376.55M | 105.83 | -0.70% | ― | 28.42% | 48.33% | |
46 Neutral | C$217.46M | -0.36 | -24.12% | 3.15% | 19.33% | -0.50% | |
44 Neutral | $456.45M | ― | -98.42% | ― | -4.24% | 55.82% | |
44 Neutral | C$4.90M | ― | ― | -13.46% | 94.86% | ||
40 Underperform | C$2.79M | ― | -21.61% | ― | ― | ― |
Vencanna Ventures reported its interim financial results for the three months ending January 31, 2025, highlighting a strategic shift following its acquisition of The Cannavative Group. The company has been focusing on operational efficiencies and cost reductions, including moving to a smaller facility in Nevada to better align with its product focus on pre-rolls. In New Jersey, Vencanna is advancing its presence with new cultivation and retail sites. Despite a decrease in revenue, the company achieved a higher gross profit due to reduced costs, although it reported a comprehensive loss primarily due to expenses related to the Cannavative acquisition and facility relocation.